Banyoles, Spain

Carles Chetrit Russi

USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Carles Chetrit Russi: Innovator in Immunostimulant Compositions

Introduction

Carles Chetrit Russi is a notable inventor based in Banyoles, Spain. He has made significant contributions to the field of immunology through his innovative work on immunostimulant compositions. His research focuses on enhancing immune function, particularly in the context of diseases and treatments that compromise the immune system.

Latest Patents

Carles Chetrit Russi holds a patent for "Immunostimulant compositions comprising a nucleobase and a polysaccharide obtainable from fungi, yeast or bacteria." This invention relates to compositions that include nucleobases and polysaccharides derived from extracts of fungi, yeasts, or bacteria. The compositions are particularly beneficial in treating and preventing immunosuppression, as well as mitigating the toxicity associated with chemotherapy or radiotherapy. They are also useful in stimulating immune function in mammals, including humans.

Career Highlights

Carles Chetrit Russi is associated with Bioiberica, S.A., a company dedicated to the development of innovative health solutions. His work at Bioiberica has allowed him to explore the therapeutic potential of natural compounds in enhancing immune responses.

Collaborations

Throughout his career, Carles has collaborated with esteemed colleagues such as Josep Escaich Ferrer and Daniel Martinez Puig. These collaborations have further enriched his research and contributed to the advancement of immunological therapies.

Conclusion

Carles Chetrit Russi is a pioneering inventor whose work in immunostimulant compositions has the potential to significantly impact the treatment of immune-related conditions. His contributions to the field highlight the importance of innovation in healthcare and the ongoing quest for effective therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…